Observational study of cerebral hemodynamics during dopamine treatment in hypotensive ELBW infants on the first day of life

J Perinatol. 2013 Sep;33(9):698-702. doi: 10.1038/jp.2013.44. Epub 2013 Apr 25.

Abstract

Objective: To evaluate cerebral hemodynamics during dopamine treatment in hypotensive (mean arterial blood pressure (MABP)<gestational age) extremely low birth weight (ELBW) infants.

Study design: Continuous monitoring of cerebral blood flow velocity (CBFv), MABP and PCO2 was performed in hypotensive ELBW infants on the first day of life, beginning with an ∼15-min baseline reading and continued during advancing dopamine infusion until MABP was optimized. Physiological variables and CBFv reactivity were compared before and after MABP was optimized.

Result: Fifteen hypotensive ELBW infants (625±174 g; 24 (23 to 24.8) weeks) were studied. Mean CBFv increased from 10.9±3.7 to 15.7±5.7 cm s(-1) (P=0.001) simultaneously as MABP increased from 22.3±2.8 to 35.2±9.7 mm Hg (P<0.001). Mean CBFv reactivity (95% confidence interval (CI)) was 3.9 (1.6 to 6.2) %mm Hg(-1). Nine infants died and/or developed severe intraventricular hemorrhage (IVH).

Conclusion: Mean CBFv increased pressure-passively as MABP was optimized by dopamine treatment in very sick hypotensive ELBW infants on the first day of life.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Flow Velocity
  • Cardiotonic Agents / therapeutic use*
  • Cerebrovascular Circulation / physiology*
  • Dopamine / therapeutic use*
  • Female
  • Humans
  • Hypotension / drug therapy*
  • Hypotension / physiopathology*
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / drug therapy
  • Infant, Premature, Diseases / physiopathology*
  • Male
  • Prospective Studies

Substances

  • Cardiotonic Agents
  • Dopamine